sábado, 7 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 26, 2025

6 Major Investment Themes Shaping 2026

View original at finance.yahoo.com
“following estimated 2025 earnings growth of 21.7% on 11.9% higher revenues”
Verbatim excerpt from the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The AI infrastructure cycle is far from complete and current phase resembles late-1990s infrastructure buildout

    80% confidence
  • Gold has risen nearly 70% this year and more than doubled S&P 500's return over past three years

    80% confidence
  • Photovoltaic module costs have fallen by roughly 90% over past decade

    80% confidence
  • Estimated 2025 earnings growth of 21.7% on 11.9% higher revenues for Magnificent Seven

    80% confidence
  • Gold is now the anti-fragile asset to own, rather than Treasuries. High-quality equities and gold are the best hedges

    80% confidence
  • Artificial intelligence was a key driver of returns, cementing itself as the most important business and technological shift since the internet

    80% confidence
  • Total AI-related capital expenditures approach $1 trillion

    80% confidence
  • Big Tech companies continue to combine strong revenue growth, rising profitability, and elevated yet defensible valuations

    80% confidence
  • Lithium-ion battery pack costs declined 20% over past year, reaching record low of $108 per kilowatt-hour

    80% confidence
  • Battery costs down nearly 90% over past decade

    80% confidence
  • Solar is now among cheapest sources of new power generation across much of United States

    80% confidence
  • US LNG export capacity set to expand meaningfully

    80% confidence
  • Earnings for rest of S&P 500 projected to grow 10.8% in 2026, up from 8.3% in 2025, 4.4% in 2024, and -4.8% in 2023

    80% confidence
  • Total 2026 earnings for Magnificent Seven expected to rise 16.5% on 15% revenue growth

    80% confidence
  • There are few signs of an imminent economic slowdown

    80% confidence
  • Solar is the fastest growing and most scalable source of new energy at a time when electricity demand is soaring

    80% confidence
  • Traditional 60/40 stock-bond portfolio no longer reflects today's market realities, suggesting 60/20/20 approach with gold replacing half bond allocation

    80% confidence
  • Global AI-related capex is projected to exceed $500 billion

    80% confidence
  • Bitcoin has never had two consecutive years of annual losses

    80% confidence
  • The bull market remains intact, and the opportunity set heading into 2026 is plentiful

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,996
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,996 hechos verificados con la fuente5,552 documentos fuente archivados
Consulta estos datos → isubstrate.com
6 Major Investment Themes Shaping 2026 — Source | Via News | es.VIA.NEWS